文献速递糖尿病肥胖与代谢综合征

脂联素与类风湿关节炎患者糖尿病发生风险的关联

Associations Between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

这项前瞻性队列研究纳入2595例类风湿关节炎患者,发现脂联素与糖尿病发生风险呈U型关系;脂联素>40 μg/mL者较10-40 μg/mL者风险更高(HR 1.70 [1.34, 2.16],P < .001),且该组炎症细胞因子水平更高,提示炎症状态下脂联素与糖尿病风险的关系发生改变。

要点

  • 在类风湿关节炎患者中,脂联素与糖尿病发生风险呈U型关系。
  • 脂联素>40 μg/mL者糖尿病风险高于10-40 μg/mL者(HR 1.70 [1.34, 2.16],P < .001)。
  • 脂联素>40 μg/mL者炎症细胞因子水平显著更高,炎症状态下脂联素与糖尿病风险关系发生改变。

核心结论

  • 在类风湿关节炎患者中,脂联素与糖尿病发生风险的关系呈U型。
  • 脂联素水平非常高者全身炎症更重,脂联素与糖尿病风险的关系发生改变。

研究设计与样本

  • 前瞻性队列研究,纳入退伍军人事务部类风湿关节炎登记处的成人类风湿关节炎患者。
  • 在入组时检测储存血清样本中的脂联素和炎症细胞因子/趋化因子。
  • 将脂联素水平分为<10 μg/mL、10-40 μg/mL、>40 μg/mL三类。
  • 采用多变量Cox比例风险模型评估脂联素与糖尿病发生的关联,调整年龄、性别、种族、吸烟状态、体重指数、改善病情抗风湿药使用、日历年和合并症。
  • 在炎症细胞因子/趋化因子升高背景下进行效应修饰检验。

主要发现

  • 共纳入2595例患者,其中脂联素>40 μg/mL者379例(15%),该组年龄更大、体重指数更低。
  • 在入组时无糖尿病的1689例患者中,新发糖尿病125例。
  • 脂联素与糖尿病发生呈负相关,但在脂联素>40 μg/mL的患者中关联为正向。
  • 脂联素>40 μg/mL者与10-40 μg/mL者相比糖尿病风险更高(HR 1.70 [1.34, 2.16],P < .001)。
  • 脂联素>40 μg/mL者炎症细胞因子水平显著更高,有证据表明炎症状态下脂联素对糖尿病风险的效应发生改变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated associations between adiponectin and the risk of diabetes among patients with rheumatoid arthritis (RA), a systemic inflammatory disease associated with metabolic disturbance. METHODS: This prospective cohort study included adults with RA from the Veterans Affairs Rheumatoid Arthritis Registry. Adiponectin and inflammatory cytokines/chemokines were measured at enrollment on stored serum samples. Adiponectin levels were categorized, and clinical variables were described across categories (<10 μg/mL; 10-40 μg/mL; >40 μg/mL). Multivariable Cox proportional hazard models evaluated associations between adiponectin and incident diabetes adjusting for age, sex, race, smoking status, body mass index (BMI), disease-modifying therapy use, calendar year, and comorbidity. Testing for modification of effect in the context of elevated cytokines/chemokines was performed. RESULTS: Among 2595 patients included in the analysis, those with adiponectin levels >40 μg/mL (N = 379; 15%) were older and had lower BMI. There were 125 new cases of diabetes among 1689 patients without prevalent disease at enrollment. There was an inverse association between adiponectin and incident diabetes; however, the association was positive among patients with adiponectin levels >40 μg/mL. Patients with levels >40 μg/mL were at higher risk compared to those with levels 10-40 μg/mL (HR: 1.70 [1.34, 2.16] P < .001). Those with adiponectin levels >40 μg/mL had significantly higher levels of inflammatory cytokines with evidence of a modified effect of adiponectin on diabetes risk in the setting of inflammation. CONCLUSION: The relationship between adiponectin and incident diabetes risk is U-shaped in RA. Patients with very high adiponectin levels have greater systemic inflammation and an altered relationship between adiponectin and diabetes risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Baker JF, England BR, Wysham KD, et al. Associations Between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis. J Clin Endocrinol Metab. 2024. PMID: 38189426. doi:10.1210/clinem/dgae010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。